Literature DB >> 26575121

Serum miR-21 may be a Potential Diagnostic Biomarker for Diabetic Nephropathy.

J Wang1, L Duan2, L Tian1, J Liu1, S Wang3, Y Gao4, J Yang5.   

Abstract

MiRNAs play important roles in initiation and progress of many pathologic processes. MiR-21 was closely associated with diabetic nephropathy (DN). However, whether serum miR-21 was as a potential diagnostic biomarker for DN and the relationship between serum miR-21 and tissue miR-21 remained unclear. In this study, real-time RT-PCR, cell transfection, luciferase reporter gene assays, western blot and confocal microscope were used, respectively. Here, we found that serum and renal tissue miR-21 was significantly elevated with the progress of DN. Moreover, luciferase reporter gene assays showed that smad7 was a validated miR-21 target, cell transfection showed that miR-21 overexpression downregulated target smad7 expression. Interestingly, serum miR-21 was significantly consistent with the alterations of tissue miR-21 with the development of DN. In addition, serum miR-21 was also positively correlated with GBM, GA, ACR and CCF, while negatively correlated with Ccr. Importantly, antagomiR-21 not only alleviated GBM, GA, ACR and CCF, but also ameliorated Ccr by increasing target smad7. In conclusion, our data demonstrated that serum miR-21 was closely associated with renal structure and function, and serum miR-21 may be regarded as a potential diagnostic biomarker of DN. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26575121     DOI: 10.1055/s-0035-1565095

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  10 in total

Review 1.  MicroRNAs in kidney injury and disease.

Authors:  Nassim Mahtal; Olivia Lenoir; Claire Tinel; Dany Anglicheau; Pierre-Louis Tharaux
Journal:  Nat Rev Nephrol       Date:  2022-08-16       Impact factor: 42.439

2.  Micro-ribonucleic acid modulation with oxidative stress and inflammation in patients with type 2 diabetes mellitus - a review article.

Authors:  Aleksandra Klisic; Irena Radoman Vujacic; Jelena Munjas; Ana Ninic; Jelena Kotur-Stevuljevic
Journal:  Arch Med Sci       Date:  2022-04-10       Impact factor: 3.707

Review 3.  MicroRNA-21: A Critical Pathogenic Factor of Diabetic Nephropathy.

Authors:  Shuijiao Liu; Weizhou Wu; Jian Liao; Fuqin Tang; Ge Gao; Jing Peng; Xiujing Fu; Yuqin Zhan; Zhihui Chen; Weifang Xu; Shankun Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-05       Impact factor: 6.055

4.  Urinary IgG, serum CX3CL1 and miRNA-152-3p: as predictors of nephropathy in Egyptian type 2 diabetic patients.

Authors:  Aml E Abdou; Haneya A A Anani; Hanan F Ibrahim; Eman Elshohat Ebrahem; Nora Seliem; Eman M I Youssef; Niveen M Ghoraba; Asmaa S Hassan; Marwa A A Ramadan; Eman Mahmoud; Shorouk Issa; Hend M Maghraby; Eman K Abdelrahman; Hala Ali Mohammed Hassan
Journal:  Tissue Barriers       Date:  2021-10-23

Review 5.  MicroRNA and Microvascular Complications of Diabetes.

Authors:  F Barutta; S Bellini; R Mastrocola; G Bruno; G Gruden
Journal:  Int J Endocrinol       Date:  2018-03-07       Impact factor: 3.257

6.  Expression Profiling and Clinical Significance of Plasma MicroRNAs in Diabetic Nephropathy.

Authors:  Jianqin Wang; Gouqin Wang; Yaojun Liang; Xiaochun Zhou
Journal:  J Diabetes Res       Date:  2019-05-14       Impact factor: 4.011

Review 7.  MicroRNAs in Chronic Kidney Disease: Four Candidates for Clinical Application.

Authors:  Linsey J F Peters; Jürgen Floege; Erik A L Biessen; Joachim Jankowski; Emiel P C van der Vorst
Journal:  Int J Mol Sci       Date:  2020-09-07       Impact factor: 5.923

Review 8.  Non-coding RNAs underlying the pathophysiological links between type 2 diabetes and pancreatic cancer: A systematic review.

Authors:  Fariba Dehghanian; Zahra Azhir; Sheyda Khalilian; Björn Grüning
Journal:  J Diabetes Investig       Date:  2021-12-14       Impact factor: 4.232

Review 9.  TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation.

Authors:  Agnieszka Loboda; Mateusz Sobczak; Alicja Jozkowicz; Jozef Dulak
Journal:  Mediators Inflamm       Date:  2016-08-17       Impact factor: 4.711

Review 10.  The Dynamics and Plasticity of Epigenetics in Diabetic Kidney Disease: Therapeutic Applications Vis-à-Vis.

Authors:  Feng-Chih Kuo; Chia-Ter Chao; Shih-Hua Lin
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.